K. Fielding

发表

Drug-mediated and cellular immunotherapy in multiple myeloma.

D. Ritchie, P. Neeson, H. Quach, 2010, Immunotherapy.

lymphoblastic leukemia regimen enhances long-term outcomes in Philadelphia positive acute UKALLXII/ECOG2993: addition of imatinib to a standard treatment

M. Tallman, L. Foroni, G. Gerrard, 2014 .

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer

J. Scholefield, J. Hardcastle, P. Guillou, 2001, British Journal of Cancer.

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib

J. Trapani, M. Smyth, H. Prince, 2015, Oncoimmunology.